TELEPHARMACY SOLUTIONS, INC. – Trademark Portfolio
Entity Type: 03
TELEPHARMACY SOLUTIONS, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TELEPHARMACY SOLUTIONS. The owner is based in Buffalo Grove, IL.
1400 Busch Parkway
Buffalo Grove, IL 60089
Showing of trademarks Trademarks
Trademark Classifications
TELEPHARMACY SOLUTIONS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does TELEPHARMACY SOLUTIONS, INC. have?
TELEPHARMACY SOLUTIONS, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.
What trademark classes does TELEPHARMACY SOLUTIONS, INC. file in?
TELEPHARMACY SOLUTIONS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TELEPHARMACY SOLUTIONS, INC.'s most well-known trademarks?
TELEPHARMACY SOLUTIONS, INC.'s registered trademark portfolio includes well-known marks such as TELEPHARMACY SOLUTIONS. These are among 1 currently registered trademark in the portfolio.
What is TELEPHARMACY SOLUTIONS, INC.'s trademark registration success rate?
TELEPHARMACY SOLUTIONS, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.